Riddhi Siddhi Gluco Biols FY26 consolidated loss widens
Riddhi Siddhi Gluco Biols Limited announced its audited financial results for FY26, reporting a standalone net profit of ₹5,630.56 lakh, a decline from ₹9,411.91 lakh in FY25, while consolidated net loss widened to ₹1,222.95 lakh. The consolidated loss was driven by a ₹2,784.33 lakh impairment on discontinued operations at subsidiary Shree Rama Newsprint Limited. Total consolidated income increased to ₹30,444.64 lakh. The Board recommended a final dividend of ₹3 per share and approved the appointment of an internal auditor and a postal ballot for shifting the registered office.
*this image is generated using AI for illustrative purposes only.
Riddhi Siddhi Gluco Biols Limited announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, following a Board meeting held on May 25, 2026. The company reported a standalone net profit of ₹5,630.56 lakh for the fiscal year, a decrease from the ₹9,411.91 lakh recorded in the previous year. For the quarter ended March 31, 2026, the standalone net profit stood at ₹517.58 lakh. The company also issued a corrigendum to the consolidated audited financial results to rectify an inadvertent error related to Current Tax Assets (Net) amounting to ₹39.94 lakh.
Standalone Financial Performance
The standalone total income for the financial year 2025-26 was ₹30,264.42 lakh, up from ₹21,194.16 lakh in the prior year. Revenue from operations for the year was ₹20,312.55 lakh, compared to ₹9,137.99 lakh in FY25. The company's total expenses for the year increased to ₹23,618.93 lakh from ₹10,939.02 lakh in the previous year.
| Particulars | Year Ended 31.03.2026 (₹ in lakhs) | Year Ended 31.03.2025 (₹ in lakhs) |
|---|---|---|
| Total Income | 30,264.42 | 21,194.16 |
| Revenue from Operations | 20,312.55 | 9,137.99 |
| Total Expenses | 23,618.93 | 10,939.02 |
| Profit Before Tax | 6,645.49 | 10,255.14 |
| Net Profit | 5,630.56 | 9,411.91 |
Consolidated Results
On a consolidated basis, the company reported a net loss of ₹1,222.95 lakh for the financial year ended March 31, 2026, compared to a net loss of ₹1,216.79 lakh in the previous year. The consolidated results include the performance of subsidiary Shree Rama Newsprint Limited. The results were impacted by an impairment loss of ₹2,784.33 lakh recognised on assets classified as discontinued operations. Total consolidated income for the year rose to ₹30,444.64 lakh from ₹22,328.39 lakh in the previous year.
Regulatory and Corporate Updates
The Board of Directors has recommended a final dividend of ₹3 per equity share for the financial year ended March 31, 2026. This dividend is equivalent to 30% of the face value of the equity shares and is subject to the approval of the shareholders. The Board approved the appointment of M/s. J S Varma & Co, Chartered Accountants, as the Internal Auditor for the financial year 2026-27. Additionally, the Board approved a notice for a postal ballot to seek shareholder approval for amending the Memorandum of Association and shifting the registered office from Gujarat to Haryana.
Historical Stock Returns for Riddhi Siddhi Gluco Biols
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.23% | +12.55% | +1.42% | +60.68% | +30.75% | +134.98% |
How might the proposed shift of Riddhi Siddhi Gluco Biols' registered office from Gujarat to Haryana impact its operational strategy, tax positioning, and proximity to key markets or raw material sources?
Given the persistent consolidated net losses driven by Shree Rama Newsprint Limited's discontinued operations, what is the company's timeline and strategy for fully divesting or resolving this subsidiary?
With standalone revenue from operations more than doubling year-over-year, what specific business segments or new contracts are driving this growth, and is this trajectory sustainable into FY2026-27?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
